We observed that infiltration by IL-22 immune cells is significantly associated with an increased 5-year survival rate, independently of known prognostic factors including age, sex, T stage, N stage, tumor grade, vascular invasion, tumor border configuration, and microsatellite stability. Here, IL22 is linked to neoplasm.